News

IBM’s savvy move to share 500 patents may spark innovation in computer software and in how companies handle IP.

One of Europe’s biggest research organisations, Fraunhofer Gesellschaft in Germany, is pushing to close its first venture fund to finance spin-off companies from the institute.

Mary Lisbeth D'Amico's first fortnightly funding column reveals how coming out on top in a start-up talent show does not guarantee funding.

Oslo-based anticancer company Algeta has closed a series A financing round totaling €23 million.

Nemerix, a semiconductor company spun out from the Swiss Federal Institute of Technology in Zurich, has closed a €25 million series B financing round.

A new life-science fund said it raised €240.3 million – and promptly announced its first two investments.

Europe looks increasingly likely to follow America’s lead and require drug companies to test their products in children. But Europe's pharma lack the resources to carry out drug trials in children — so industry and patients will have to rely on the skills developed in academic centres.